Jazz Pharmaceuticals, the Dublin-based maker of the narcolepsy treatment Xyrem, is buying Italian rare disease drug developer Gentium in a $1 billion (...)

Investors in pharmaceuticals businesses are a nervous bunch as Bruce Cozadd and his team at Dublin-based Jazz Pharmaceuticals discovered this w(...)